Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong... Show more
Industry MedicalDistributors
A.I.dvisor tells us that HKPD and SCNX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKPD and SCNX's prices will move in lockstep.
| Ticker / NAME | Correlation To HKPD | 1D Price Change % | ||
|---|---|---|---|---|
| HKPD | 100% | +3.65% | ||
| SCNX - HKPD | 31% Poorly correlated | -2.69% | ||
| COSM - HKPD | 20% Poorly correlated | +0.16% | ||
| YI - HKPD | 11% Poorly correlated | +7.85% | ||
| HITI - HKPD | 9% Poorly correlated | -1.17% | ||
| FOCL - HKPD | 7% Poorly correlated | -1.44% | ||
More | ||||
| Ticker / NAME | Correlation To HKPD | 1D Price Change % |
|---|---|---|
| HKPD | 100% | +3.65% |
| Medical Distributors industry (11 stocks) | 10% Poorly correlated | +0.23% |
| Distribution Services industry (59 stocks) | 7% Poorly correlated | +0.60% |
HKPD saw its Momentum Indicator move below the 0 level on August 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator turned negative. In 23 of the 23 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HKPD turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 9 similar instances when the indicator turned negative. In 9 of the 9 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
HKPD moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HKPD crossed bearishly below the 50-day moving average on August 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HKPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
HKPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.630) is normal, around the industry mean (7.715). HKPD has a moderately low P/E Ratio (6.136) as compared to the industry average of (19.412). HKPD's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.318). HKPD's Dividend Yield (0.000) is considerably lower than the industry average of (0.007). P/S Ratio (0.149) is also within normal values, averaging (4.328).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. HKPD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HKPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.